We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRHC
4551
DELISTED
Cohn Robbins Holdings Corp.
CRHC
-381,719
Closed -$3.75M
QNGY
4552
DELISTED
Quanergy Systems, Inc.
QNGY
-598
Closed -$120K
ASAQ.WS
4553
CALL
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
-24,800
Closed -$18K
AMPE
4554
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-59
Closed -$30K
NMMC
4555
DELISTED
North Mountain Merger Corp. Class A Common Stock
NMMC
-800,000
Closed -$7.94M
RWGV
4556
DELISTED
Direxion Russell 1000 Growth Over Value ETF
RWGV
-20,086
Closed -$2.02M
MNDT
4557
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
-216,700
Closed -$4.24M
NBEV
4558
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
-14,377
Closed -$41K
RTLR
4559
DELISTED
Rattler Midstream LP Common Units
RTLR
-10,498
Closed -$112K
ACTDU
4560
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
-60,000
Closed -$600K
ENJY
4561
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
-700,000
Closed -$6.92M
GGPIU
4562
DELISTED
Gores Guggenheim, Inc. Unit
GGPIU
-60,000
Closed -$596K
EJFAU
4563
DELISTED
EJF Acquisition Corp. Unit
EJFAU
-10,000
Closed -$100K
VGII.U
4564
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
-2,405,515
Closed -$23.9M
CALA
4565
DELISTED
Calithera Biosciences, Inc
CALA
-1,536
Closed -$74K
ZNGA
4566
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-652,000
Closed -$6.66M
SRGA
4567
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-359
Closed -$23K
EVFM
4568
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
-1,168
Closed -$31K
TLMD
4569
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
-17,343
Closed -$109K
GSKY
4570
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
-11,939
Closed -$74K
FMAC
4571
DELISTED
FirstMark Horizon Acquisition Corp.
FMAC
-12,910
Closed -$129K
RESN
4572
DELISTED
Resonant Inc.
RESN
-12,477
Closed -$53K
SC
4573
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-13,609
Closed -$368K
NEW
4574
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
-31,856
Closed -$1.27M
ODT
4575
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
-13,738
Closed -$47K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.